September 11th 2024
Wendie Berg. MD, PhD, explains new breast density reporting standards, cancer risks, and the importance of supplemental imaging for dense breast tissue.
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine
View More
Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents
View More
Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine
View More
Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances
View More
Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer
View More
Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care
View More
Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials
View More
Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations
View More
FDA prepares to approve Perjeta for use pre-surgery
September 19th 2013The Food and Drug Administration’s (FDA) advisory committee cleared the way for the approval of pertuzumab (Perjeta) to treat patients before they have surgery to remove their HER2-positive tumors. If approved, pertuzumab would be the first neoadjuvant drug approval for any form of cancer. The drug was already approved by the FDA for treatment of late-stage breast cancer last year.
Read More
Women who don’t get mammograms most likely to die of breast cancer
September 19th 2013A new multicenter analysis shows that most deaths from invasive breast cancer occur in women who don’t get routine mammograms. The findings, published in Cancer, point to a need to encourage routine screening in women younger than age 50.
Read More
Longer tamoxifen treatment drops risk of cancer recurrence, death
June 13th 2013Prolonging treatment with adjuvant tamoxifen from 5 years to 10 years decreases risk of breast cancer recurrence (15% reduction over 5 years of therapy) as well as mortality (25% reduction at year 10) for women in the initial stages of breast cancer. Richard Gray, MD, MSc, of the University of Oxford, UK, presented this finding from results of the aTTom trial (Adjuvant Tamoxifen: To Offer More?) at the 2013 American Society of Clinical Oncology (ASCO) annual meeting in Chicago in early June.
Read More
False-positive mammograms and long-term stress
April 11th 2013A mammogram showing an abnormal finding can result in stress and anxiety for as long as 3 years for some women, even if the finding is determined to be a “false positive,” according to a study that appeared in the March/April issue of The Annals of Family Medicine.
Read More
PTSD in women facing breast cancer
March 7th 2013A study has found that nearly 1 in 4 women (23%) newly diagnosed with breast cancer reported symptoms consistent with post-traumatic stress disorder (PTSD) shortly after diagnosis. Black and Asian women were more likely to report such symptoms. The study, called “Racial Disparities in Posttraumatic Stress After Diagnosis of Localized Breast Cancer: The BQUAL Study,” has been published online ahead of print in the Journal of the National Cancer Institute.
Read More
Prioritize breast cancer prevention, posits panel
February 21st 2013On February 12, the Interagency Breast Cancer and Environmental Research Coordinating Committee (IBCERCC) released the report “Breast Cancer and the Environment: Prioritizing Prevention.” The report is a result of the Breast Cancer and Environmental Research Act, which was passed by Congress in October 2008. The act required the US Secretary of Health and Human Services (HHS) to establish the IBCERCC, composed of federal and nonfederal members, to examine the current state of breast cancer and the environment research and make recommendations for eliminating any knowledge gaps.
Read More
Practice Guidelines for Breast Cancer Follow-Up After Primary Treatment
December 12th 2012A review of new publications by the Update Committee for the American Society of Clinical Oncology found that the guidelines for the follow-up and management of patients with breast cancer who have completed treatment are still sound.
Read More
Tumor Stage Affects Risk of Developing Contralateral Breast Cancer
November 16th 2012Women with primary breast cancer diagnosed at an advanced stage are at increased risk for the development of contralateral breast cancer (CBC), according to the results of a population-based study conducted in Sweden.
Read More
Lapatinib Plus Trastuzumab Improves Survival in Metastatic Breast Cancer
August 20th 2012In patients with heavily pretreated HER2-positive metastatic breast cancer, combination treatment with lapatinib and trastuzumab was associated with a median survival benefit of 4.5 months, according to the final results of a phase III study.
Read More
After Breast Cancer, Omega-3s Fight Fatigue
April 16th 2012Fatigue, which can plague patients’ years after cancer treatment has ended, may be the result of inflammation. Now, a new study published in the Journal of Clinical Oncology has found that omega-3 may help reduce fatigue associated with inflammation in these patients.
Read More
New Blood Test Improves Detection of Recurrent Breast Cancer
April 9th 2012Women with a history of breast cancer have a one in five chance that the cancer will recur within 10 years of treatment. With that in mind, researchers have developed a blood test that can detect cancer recurrence sooner and with more sensitivity than previous blood tests.
Read More
MRI Useful, Cost-Effective for Women with a Family History of Breast Cancer
April 2nd 2012Magnetic resonance imaging can be helpful and cost-effective in detecting breast cancer in certain patient populations, according to new research presented at the 8th European Breast Cancer Conference in Vienna, Austria.
Read More
The Link Between Parabens and Breast Cancer: How Much Worry Is Warranted?
January 20th 2012Over the past few years, there has been great concern over the presence of alkyl esters of p-hydroxybenzoic acid (parabens) in consumer products and their link to breast cancer. These compounds have been found in human blood, milk, urine, and breast tissue.
Read More
Update on Lymphedema: Exercise After Breast Cancer Treatment Is OK
December 20th 2011Lymphedema, swelling caused by a blockage in the lymphatic system, can occur as a result of surgical or radiation therapy associated with breast cancer treatment. Since some research has shown that exercise after breast cancer treatment has been associated with developing lymphedema, clinicians often advise patients to avoid exercising. But is this truly necessary?
Read More
FDA Rescinds Approval of Avastin for Breast Cancer
November 21st 2011In an expected move, the FDA has withdrawn its accelerated approval of Avastin (bevacizumab) for the treatment of breast cancer. Specifically, bevacizumab is no longer indicated for use in combination with paclitaxel for patients with HER2-negative metastatic breast cancer who have not undergone chemotherapy.
Read More
Nearly everyone agrees that breast milk is unmatched as the optimum source of nutrition for infants. Human milk not only provides the perfect balance of vitamins, minerals, protein, carbohydrates and fat, it also contains valuable antibodies from the mother that have been proven helpful in preventing infection in infants.
Read More
The purpose of breast compression is to continue the flow of milk to the baby once the baby no longer drinks (open-pause-close type of suck) on his own. Breast compression simulates a letdown reflex and often stimulates a natural letdown reflex to occur. The technique may be useful for
Read More